News Archive

News Archive - Page 8 of 30 - Real Endpoints

Dec 29, 2023

CVS Plans to Overhaul How Much Drugs Cost

The big news stories of the last two weeks underscore how policy changes, or potential policy changes, are influencing how healthcare is delivered and paid for. Last week's news: the Humana-Cigna tie-up (assuming the deal receives the FTC's blessing, an open question).

read full article ›

Dec 29, 2023

Cigna Follows Mark Cuban’s Lead to Make Drug Prices Simpler

This is an interesting move by Cigna/Express Scripts. For starters, it shows how Mark Cuban's approach to pharmacy benefits is encouraging a shift in the broader PBM business model. (The specter of regulation probably plays a role, too). What will be interesting to see is if Cigna is better placed than other PBM disruptors to execute on the model given their vertical integration.

read full article ›

Dec 29, 2023

Real Endpoints on the ground with EU Biotech leaders

Real Endpoints spent a busy week on the ground with EU Biotech leaders. The US market is increasingly opaque and complicated for entry by European biotechs, more so with the impending implementation of the #inflationreductionact. If you are an early-stage EU based biotech and curious about the trends we are seeing, please reach out!!

read full article ›

Nov 13, 2023

RE’s Rob O’Brien at the 2024 Midwest AMCP day of eduction in Chicago

Truly honored to be asked back to support this year's Midwest AMCP day of education - Chicago! It is an impressive agenda, and I am excited to be moderating a panel with these fellow pharmacy experts. Megan Wagner, Alex J. and Greg Baker! It's just a week away - registration information below! Looking forward to seeing so many colleagues, friends and industry experts - see you there!

read full article ›

Nov 13, 2023

Zepbound’s approval and Eli Lilly’s press release

Eli Lilly's press release yesterday about Zepbound's approval is another example of a pharma using regulatory news to address pricing and product access head on. Like Brian Reid of The Cost Curve newsletter, we think this kind of transparency can be beneficial, allowing a company to have greater control over the value narrative.

read full article ›

Nov 13, 2023

FDA Approves New Medication for Chronic Weight Management

Unleash the beast! The potential payor dynamics and impact surrounding the obesity market will have a profound impact on pricing and reimbursement issues in this category and beyond. Look out for some interesting pricing battles in the days to come.

read full article ›

Nov 13, 2023

Welcome to Real Endpoints, Jeff Parish!

We are so excited to announce that Jeff Parish has joined Real Endpoints. Jeff's deep consultative business development experience will accelerate our next phase of growth and further deepen our client relationships as we continue to develop new solutions to achieve market access for innovative products.

read full article ›

Nov 13, 2023

RE’s Rob O’Brien at the Digital Health Summit

Very excited to be attending the Digital Health Summit on 10/25 - hosted by The Center of Technology and Behavior Health. To learn more, see below. Rob O'Brien will be hosting a panel discussion focused on, the value proposition of digital therapeutics and paths to deployment and strategies to achieve payer buy-in. Have an all-star panel that includes...Reena Pande, Jason Parent, MSN, APRN, FNP-C, Jeffrey Abraham, Brendan Hare! Looking forward to the great agenda and connecting with the various stakeholders attending!

read full article ›

Nov 13, 2023

RE Assist named as a finalist in the Financial/Operational Solutions category of the 2023 Fierce Healthcare Innovation Awards

We are thrilled that RE Assist was named as a finalist in the Financial/Operational Solutions category of the 2023 Fierce Healthcare Innovation Awards. It's a validation of Real Endpoints work to create a tangible solution for #copay challenges faced by #Medicare patients. To our fellow finalists - congratulations! It's an honor to be in such exalted company.

read full article ›